Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
A Collaborative Approach To The Treatment Of Pregnant Women With Opioid Use Disorders
Download A Collaborative Approach To The Treatment Of Pregnant Women With Opioid Use Disorders full books in PDF, epub, and Kindle. Read online A Collaborative Approach To The Treatment Of Pregnant Women With Opioid Use Disorders ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis A Collaborative Approach to the Treatment of Pregnant Women With Opioid Use Disorders by : Department Of Health And Human Services
Download or read book A Collaborative Approach to the Treatment of Pregnant Women With Opioid Use Disorders written by Department Of Health And Human Services and published by . This book was released on 2017-10-12 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: "This guidance publication is intended to support the efforts of states, tribes, and local communities in addressing the needs of pregnant women with opioid use disorders and their infants and families. National data show that from 2000 to 2009 the use of opioids during pregnancy increased from 1.19 to 5.63 per 1,000 hospital births. Because of the high rate of opioid use and misuse among all women, including pregnant women, medical, social service, and judicial agencies are having to confront this concern more often and, in some communities, at alarming rates"--Introduction
Book Synopsis A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disoders by :
Download or read book A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disoders written by and published by . This book was released on 2016 with total page 116 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Opioid-Use Disorders in Pregnancy by : Tricia E. Wright
Download or read book Opioid-Use Disorders in Pregnancy written by Tricia E. Wright and published by . This book was released on 2018-05-10 with total page 155 pages. Available in PDF, EPUB and Kindle. Book excerpt: Gain guidance and support when treating the high-risk population of women confronting (or battling) opioid-use disorders during pregnancy.
Book Synopsis Treating Women with Substance Use Disorders During Pregnancy by : Hendree E. Jones
Download or read book Treating Women with Substance Use Disorders During Pregnancy written by Hendree E. Jones and published by Oxford University Press. This book was released on 2013-03-28 with total page 229 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book provides a first in-depth, comprehensive, and evidenced-based overview of the treatment of substance use disorders in the pregnant patient. It provides readers with materials that will not only aid them in identifying, assessing, and understanding the issues involved in treating these women, but also the practical tools to implement the best practices from comprehensive care programs specializing in this sort of treatment. Each chapter strikes a balance between the best scientific information available and reasoned, clinical wisdom to fill in where evidence-based information is unavailable — all in a form that is practical and accessible. It is a valuable tool for clinicians and service providers across disciplines.
Author :National Academies of Sciences, Engineering, and Medicine Publisher :National Academies Press ISBN 13 :0309486483 Total Pages :175 pages Book Rating :4.3/5 (94 download)
Book Synopsis Medications for Opioid Use Disorder Save Lives by : National Academies of Sciences, Engineering, and Medicine
Download or read book Medications for Opioid Use Disorder Save Lives written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2019-06-16 with total page 175 pages. Available in PDF, EPUB and Kindle. Book excerpt: The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Book Synopsis Opioid-Use Disorders in Pregnancy by : Tricia E. Wright
Download or read book Opioid-Use Disorders in Pregnancy written by Tricia E. Wright and published by Cambridge University Press. This book was released on 2018-05-10 with total page 155 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book will help readers gain vital guidance and support when treating the high-risk, high-reward population of women confronting (or battling) opioid-use disorders during pregnancy. Large numbers of pregnant women are dependent on opioids and require comprehensive non-judgemental care to replace traditional approaches of incarceration and child welfare involvement that worsen outcomes for both mother and infant. Invaluable and comprehensive, this toolkit provides the key to non-judgemental care for both mother and baby, throughout labor, delivery management and postpartum care. It bridges the important treatment gap through evidence-based, caring approach; standardizing exceptional care, for obstetricians, pediatricians, addictionists, and anyone caring for pregnant women with opioid-use disorders. Edited by a Board-certified expert in obstetrics, gynecology and addiction medicine, and a team of internationally-acclaimed leaders in women's health, this guide provides high-quality advice, guidelines and vital skills to tackle a currently expanding opioid epidemic.
Author :National Academies of Sciences, Engineering, and Medicine Publisher :National Academies Press ISBN 13 :0309459575 Total Pages :483 pages Book Rating :4.3/5 (94 download)
Book Synopsis Pain Management and the Opioid Epidemic by : National Academies of Sciences, Engineering, and Medicine
Download or read book Pain Management and the Opioid Epidemic written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2017-09-28 with total page 483 pages. Available in PDF, EPUB and Kindle. Book excerpt: Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Book Synopsis Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy by : World Health Organization
Download or read book Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy written by World Health Organization and published by . This book was released on 2015-04-20 with total page 37 pages. Available in PDF, EPUB and Kindle. Book excerpt: These guidelines have been developed to enable professionals to assist women who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder, to achieve healthy outcomes for themselves and their fetus or infant. They have been developed in response to requests from organizations, institutions and individuals for technical guidance on the identification and management of alcohol, and other substance use and substance use disorders in pregnant women. They were developed in tandem with the WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy.
Book Synopsis Reproductive Aged and Pregnant Women with Opioid Use Disorder by : Shayna Mazel
Download or read book Reproductive Aged and Pregnant Women with Opioid Use Disorder written by Shayna Mazel and published by . This book was released on 2024 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Opioid use disorder (OUD) among pregnant and non-pregnant women of reproductive age continues to be a significant public health concern in the U.S. Using opioids during pregnancy poses significant health risks, including fatal overdose, infectious disease exposure, and other major health concerns. Among individuals who use opioids during pregnancy, co-occurring substance use is common, specifically alcohol, stimulant and cannabis use. Data from the Centers for Disease Control and Prevention indicate that 7 percent of pregnant women reported using opioids during pregnancy in 2019, a figure which has trended upward for the past two decades. Despite long-standing recognition of medications for opioid use disorder (MOUD) as the gold standard of care to treat OUD among pregnant and reproductive-aged women, most will not receive treatment. Additionally, Medicaid pays the largest portion of OUD-related healthcare costs for pregnant women, solidifying substance use during pregnancy as a critical policy issue for the Federal government. The 21st Century Cures Act, passed in 2016, dedicated $1 billion toward prevention, treatment, and recovery efforts, with states receiving funding through State-Targeted Response (STR) grants to increase state-specific opioid funding. Funded programs include Washington State's hub and spoke model to increase access to medication treatment for OUD, which began in 2017. While increasing MOUD receipt is the core of these efforts, it is unclear to what extent these investments have been successful for pregnant and non-pregnant women of reproductive age. Further, less is known more broadly about how pregnancy affects treatment access and healthcare utilization, if and how treatment continues post-pregnancy, and what healthcare utilization more holistically looks like for those who receive treatment. Using Washington state as its setting, this dissertation had three aims: 1) to understand what MOUD receipt and utilization look like for pregnant and non-pregnant women of reproductive age with co-occurring alcohol, stimulant and cannabis use disorder, explore differences of setting diagnosis for those with OUD and comorbid alcohol use disorder (AUD), and explore other OUD-related service utilization; 2) to explore pregnant women's pregnancy complications and healthcare utilization outcomes of receiving consistent MOUD versus inconsistent MOUD or no MOUD; and 3) to explore, among pregnant women who receive MOUD, the impact that receiving treatment from Washington's hub and spoke program has on their outcomes. Significant differences in MOUD outcomes among pregnant women were further examined by race/ethnicity, age, and locality, in addition to co-occurring alcohol, stimulant, and cannabis use, as well as comorbid mental health conditions. To explore these aims, the dissertation used Washington Medicaid claims data of 564 pregnant women and 564 non-pregnant women aged 18-44 from 2016-2019, while employing the Andersen behavioral model of healthcare utilization, to understand how predisposing and enabling factors impact MOUD utilization and subsequent outcomes. The methodology used was a combination of descriptive data analysis and multivariate regression analyses to understand the relationship between these factors with MOUD utilization and outcomes. Results from Aim 1 showed that while pregnant women with OUD were more likely than non-pregnant women with OUD to receive MOUD, most pregnant and non-pregnant women did not receive MOUD, including in the postpartum period. Comorbid mental health disorders were high overall. Co-occurring stimulant use disorder was more common among non-pregnant and pregnant women with OUD than AUD or cannabis use disorder; co-occurring AUD was less common among pregnant women than non-pregnant women. Both groups of women had low rates of residential, inpatient, and detoxification services, while both groups had high rates of outpatient psychosocial service utilization. Pregnant women were more likely than non-pregnant women to be diagnosed with OUD in an inpatient hospital setting, whether they had AUD or not. Aim 2 results showed that those who received MOUD had better healthcare utilization measures (e.g., more likely to receive certain health screenings) compared to those who did not receive MOUD. Pregnancy complications among all women were low and receiving consistent MOUD (i.e., six monthly medication visits prior to delivery) resulted in greater healthcare utilization. Aim 3 results were limited due to a small sample of pregnant women with OUD who received MOUD from a hub and spoke network, although it seems that hub and spoke did not affect the overall findings. The small sample size may have curtailed meaningful conclusions about how the hub and spoke system affected pregnant women's healthcare utilization and pregnancy outcomes. Results from this dissertation have important clinical and policy-related implications. Further evidence that substantiates the prevalence of polysubstance use may be useful to providers in treating reproductive aged and pregnant women with OUD, and low MOUD rates may be additional reason for universal OUD screening and brief referral to treatment. Specific findings around both low MOUD rates and low rates of certain healthcare utilization measures, such as HIV screening, may also be useful to medical associations, as they consider how to update their quality measures and guidelines, and state agencies. State policymakers and substance use programs could tailor programming for subsets of pregnant women that are most at risk of treatment underutilization. Lastly, understanding the impact of delivery system reform for substance use treatment, such as the hub and spoke model, and its impact on vulnerable, priority populations such as pregnant women is especially imperative in today's fiscally challenging policy environment.
Author :Committee on Federal Regulation of Methadone Treatment Publisher :National Academies Press ISBN 13 :0309598621 Total Pages :251 pages Book Rating :4.3/5 (95 download)
Book Synopsis Federal Regulation of Methadone Treatment by : Committee on Federal Regulation of Methadone Treatment
Download or read book Federal Regulation of Methadone Treatment written by Committee on Federal Regulation of Methadone Treatment and published by National Academies Press. This book was released on 1995-02-01 with total page 251 pages. Available in PDF, EPUB and Kindle. Book excerpt: For nearly three decades, methadone hydrochloride has been the primary means of treating opiate addiction. Today, about 115,000 people receive such treatment, and thousands more have benefited from it in the past. Even though methadone's effectiveness has been well established, its use remains controversial, a fact reflected by the extensive regulation of its manufacturing, labeling, distribution, and use. The Food and Drug Administration regulates the safety and effectiveness of methadone, as it does for all drugs, and the Drug Enforcement Administration regulates it as a controlled substance. However, methadone is also subjected to a unique additional tier of regulation that prescribes how and under what circumstances it may be used to treat opiate addiction. Federal Regulation of Methadone Treatment examines current Department of Health and Human Services standards for narcotic addiction treatment and the regulation of methadone treatment programs pursuant to those standards. The book includes an evaluation of the effect of federal regulations on the provision of methadone treatment services and an exploration of options for modifying the regulations to allow optimal clinical practice. The volume also includes an assessment of alternatives to the existing regulations.
Book Synopsis The ASAM Principles of Addiction Medicine by : Shannon Miller
Download or read book The ASAM Principles of Addiction Medicine written by Shannon Miller and published by Lippincott Williams & Wilkins. This book was released on 2018-11-26 with total page 1984 pages. Available in PDF, EPUB and Kindle. Book excerpt: Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. Thoroughly updated with the latest international evidence-based research and best practices, the comprehensive sixth edition of the American Society of Addiction Medicine’s (ASAM) official flagship textbook reviews the science and art behind addiction medicine and provides health care providers with the necessary information to not only properly diagnose and treat their patients, but to also serve as change agents to positively impact clinical service design and delivery, as well as global health care policy.
Book Synopsis Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants by : Substance Abuse and Mental Health Services Administration (US)
Download or read book Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants written by Substance Abuse and Mental Health Services Administration (US) and published by Createspace Independent Publishing Platform. This book was released on 2018-04-20 with total page 166 pages. Available in PDF, EPUB and Kindle. Book excerpt: This Guide provides comprehensive, national guidance for the optimal management of pregnant and parenting women with OUD and their infants based on the recommendations of experts reviewing the limited evidence available for this population as of 2017. In the past, only one option was available for OUD treatment in pregnant women. Today, more options are available, so healthcare professionals need to provide more education to their patients and obtain their detailed informed consent to ensure decision-making is shared between the pregnant woman or new mother and the healthcare professional. This Guide will help healthcare professionals and patients determine the most clinically appropriate action for a particular circumstance, with the expectation that the healthcare professionals will make individualized treatment decisions. A cornerstone of the Guide is that a healthy pregnancy results in a healthy infant and mother. The Guide recognizes the mother and infant as a dyad, and the recommendations are provided in light of what actions will optimize the outcomes for the mother-infant dyad as a whole, with guidance provided from preconception to several months postpartum and for the first few years of infant development.
Book Synopsis Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder by : Substance Abuse Mental Health Services Administration/SAMHSA (U.S.)
Download or read book Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder written by Substance Abuse Mental Health Services Administration/SAMHSA (U.S.) and published by Government Printing Office. This book was released on 2018-06-05 with total page 398 pages. Available in PDF, EPUB and Kindle. Book excerpt: This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and provides guidance for healthcare professionals and addiction treatment providers on appropriate prescribing practices for these medications and effective strategies for supporting the patients utilizing medication for the treatment of OUD. The goal of treatment for opioid addiction or OUD is remission of the disorder leading to lasting recovery. Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential. This TIP also educates patients, families, and the general public about how OUD medications work and the benefits they offer. Related products: Medication-Assisted Treatment of Opioid Use Disorder: Pocket Guide A Shared Burden: The Military and Civilian Consequences of Army Pain Management Since 2001 Click our Alcoholism, Smoking & Substance Abuse collection to find more resources on this topic.
Book Synopsis Neonatal Narcotic Addiction by : Jane S. Lin-Fu
Download or read book Neonatal Narcotic Addiction written by Jane S. Lin-Fu and published by . This book was released on 1967 with total page 16 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis TIP 35: Enhancing Motivation for Change in Substance Use Disorder Treatment (Updated 2019) by : U.S. Department of Health and Human Services
Download or read book TIP 35: Enhancing Motivation for Change in Substance Use Disorder Treatment (Updated 2019) written by U.S. Department of Health and Human Services and published by Lulu.com. This book was released on 2019-11-19 with total page 208 pages. Available in PDF, EPUB and Kindle. Book excerpt: Motivation is key to substance use behavior change. Counselors can support clients' movement toward positive changes in their substance use by identifying and enhancing motivation that already exists. Motivational approaches are based on the principles of person-centered counseling. Counselors' use of empathy, not authority and power, is key to enhancing clients' motivation to change. Clients are experts in their own recovery from SUDs. Counselors should engage them in collaborative partnerships. Ambivalence about change is normal. Resistance to change is an expression of ambivalence about change, not a client trait or characteristic. Confrontational approaches increase client resistance and discord in the counseling relationship. Motivational approaches explore ambivalence in a nonjudgmental and compassionate way.
Book Synopsis Medications for Opioid Use Disorder by :
Download or read book Medications for Opioid Use Disorder written by and published by . This book was released on 2018 with total page 322 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence by : John A. Renner, Jr.
Download or read book Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence written by John A. Renner, Jr. and published by American Psychiatric Pub. This book was released on 2017-12-05 with total page 400 pages. Available in PDF, EPUB and Kindle. Book excerpt: With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD) -- an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy. Among the numerous other revisions included in the second edition are the following: Information about new formulations of buprenorphine A discussion of the Comprehensive Addiction and Recovery Act (CARA) Changes to induction and maintenance target doses and recommendations for home inductions Information on diversion control plans Advice for working with Alcoholics Anonymous and Narcotics Anonymous A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs This edition can also be used to complete the 8 hours of qualifying training required for the buprenorphine waiver. By a thorough reading of the material covered in the chapters of this book and successful completion of the posttest, physicians can meet the buprenorphine waiver training requirement. Written in a jargon-free style that does not require expertise in substance use disorder treatment, Office-Based Buprenorphine Treatment of Opioid Use Disorder is an accessible, indispensable reference for primary care physicians, psychiatrists, nurse practitioners, residents, medical students, and anyone with an interest in learning about and prescribing buprenorphine.
